Search Results

HOME > SEARCH > SEARCH RESULTS

Refine by Audience:

Your search for pilot research returned 593 results.

Displaying 71 to 80 of 593 records
Sort by: Page: << Prev 5… 6… 7… 8… 9… 10… 11… Next >>

PET Imaging Validates Use of Common Cholesterol Drug to Enhance HER2-Targeted Cancer Therapy – Oct 12, 2023
A novel therapeutic approach combining HER2-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor growth, according to research published in JNM.
Strategic Plans – Oct 11, 2023
Page that provides links to both the TS and SNMMI Strategic Plans
Message from the President – Oct 10, 2023
SNMMI President Helen Nadel highlights recent achievements, global collaborations, advocacy efforts, and upcoming SNMMI meetings.
Molecular Imaging and Breast Cancer - 11/8/23, Seattle, WA – Oct 5, 2023
Dinner Symposium - Molecular Imaging and Breast Cancer: Selecting and Evaluating Targeted Treatments
Interview with Dr. Amir Iravani – Oct 3, 2023
SNMMI member interviews to inform patients.
FDA Approves Widely Used Imaging Agent for Respiratory Disease – Sep 29, 2023
The FDA has approved the imaging agent Technegas for use in ventilationperfusion studies to diagnose pulmonary embolism and other respiratory pathologies.
Novel Tau PET Tracer Exhibits High Sensitivity and Specificity, Allowing for Earlier Identification of Alzheimers Disease – Sep 28, 2023
A new tau PET radiotracer, F-18 SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimers disease in its earliest stages, according to research published in JNM.
Whole-Body PET/CT Predicts Response to HER2-Targeted Therapy in Metastatic Breast Cancer Patients – Sep 27, 2023
A new imaging agent, Ga-68-ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published in JNM.
First Three Facilities Accredited in SNMMI/IAC Radiopharmaceutical Therapy Accreditation Program – Sep 25, 2023
SNMMI and the Intersocietal Accreditation Commission are pleased to announce the first three facilities to be awarded the new Radiopharmaceutical Therapy Accreditation.
Nuclear Medicine Treatment Cures Lethal Form of Ovarian Cancer in Preclinical Setting – Sep 18, 2023
A new 225Ac-DOTA-based pre-targeted radioimmunotherapy system has been shown to cure a highly lethal form of advanced intraperitoneal ovarian cancer in a preclinical setting with minimal side effects, according to research published in JNM.

Displaying 71 to 80 of 593 records
Page: << Prev 5… 6… 7… 8… 9… 10… 11… Next >>